Eden Research plc (LON:EDEN – Get Free Report) was up 2.8% on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares changed hands during trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The stock has a market capitalization of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92. The company has a 50 day simple moving average of GBX 3.88 and a 200-day simple moving average of GBX 4.02. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- 3 Dividend Kings To Consider
- What Does the Future Hold for Eli Lilly?
- What Makes a Stock a Good Dividend Stock?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- 3 Small Caps With Big Return Potential
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
